Search Results - "Reindl, S"

Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis by Leipe, Jan, Schramm, Markus A, Grunke, Mathias, Baeuerle, Michael, Dechant, Claudia, Nigg, Axel P, Witt, Matthias N, Vielhauer, Volker, Reindl, Christiane S, Schulze-Koops, Hendrik, Skapenko, Alla

“…To study the role of interleukin 22 (IL-22) in rheumatoid arthritis (RA). IL-22 serum levels were measured in patients with early, treatment-naive RA (n=49)…”
Get more information

Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations by Balendran, S., Liebmann-Reindl, S., Berghoff, A. S., Reischer, T., Popitsch, N., Geier, C. B., Kenner, L., Birner, P., Streubel, B., Preusser, M.

“…Ovarian cancer represents the most common gynaecological malignancy and has the highest mortality of all female reproductive cancers. It has a rare…”
Get full text

Ultrasound of Synovitis in Rheumatoid Arthritis: Advantages of the Dorsal over the Palmar Approach to Finger Joints by WITT, Matthias N, MUELLER, Felix, WEINERT, Peter, NIGG, Axel P, REINDL, Christiane S, PROFT, Fabian, SCHULZE-KOOPS, Hendrik, GRUNKE, Mathias

“…To compare the dorsal and palmar ultrasound (US) examination of finger joints in early rheumatoid arthritis (RA) with regard to the concurrence of greyscale…”
Get full text

Research efforts to control highly pathogenic arenaviruses: A summary of the progress and gaps by Kerber, R, Reindl, S, Romanowski, V, Gómez, R.M, Ogbaini-Emovon, E, Günther, S, ter Meulen, J

“…Highlights • This article reviews the progress made in research on Lassa virus and the South American arenaviruses in the past 10 years, and identifies gaps in…”
Get full text

Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany by Kotowa, W, Häussler, B, Reindl, S, Höer, A

Get full text

Inpatient Case-Related Treatment Costs For Different Cardiovascular Diseases In Germany by Schädlich, P.K, Rosenfeld, S, Reindl, S, Kotowa, W

Get full text

HTA321 Factors Influencing the Shi Costs of Orphan Drugs After Their Renewed Regular Benefit Assessment Due to Exceeding the Sales Threshold in Germany by Brückel, S., Reindl, S.

Get full text

HTA29 Analysis of the Change of the Added Benefit and Respective Reasons in Renewed Regular Benefit Assessments of Orphan Drugs Due to Exceeding the Sales Threshold in Germany by Brückel, S., Reindl, S., Tran, T.T.

Get full text

Higher excited-state triplet-singlet intersystem crossing of some organic dyes by Reindl, S., Penzkofer, A.

“…Time resolved fluorescence studies of some organic dyes (erythrosin B, rose bengal, tetraphenylporphyrin) by intense picosecond double and multiple pulse…”
Get full text

Quantum yield of triplet formation for indocyanine green by Reindl, S., Penzkofer, A., Gong, S.-H., Landthaler, M., Szeimies, R.M., Abels, C., Bäumler, W.

“…Yields of triplet formation, φ S 1 T 1 , by S 1– T 1 intersystem-crossing are determined for indocyanine green in DMSO ( φ S 1 T 1 ≈ 17%), methanol ( φ S 1 T 1…”
Get full text

Triplet quantum yield determination by picosecond laser double-pulse fluorescence excitation by Reindl, S., Penzkofer, A.

“…The quantum yields of S 1 → T 1 triplet formation of some organic dyes are determined by picosecond double-pulse laser excitation and time-resolved…”
Get full text

Picosecond thermoelectric response of thin YBa2Cu3O7−δ films by Zahner, Th, Stierstorfer, R., Reindl, S., Schauer, T., Penzkofer, A., Lengfellner, H.

Get full text

PNS144 HOW THE RESULTS OF THE AMNOG EARLY BENEFIT ASSESSMENT (EBA) IN GERMANY HAVE DEVELOPED OVER TIME by Reindl, S., Kotowa, W., Mathes, J., Höer, A.

Get full text

Higher excited-state photoisomerization and singlet to triplet intersystem-crossing in DODCI by Reindl, S., Penzkofer, A.

“…An intensity dependent N-isomer fluorescence reduction was observed by picosecond laser pump and probe experiments for DODCI (3,3′-diethyloxadicarbocyanine…”
Get full text

PHP64 - Acceptance Of Indirect Comparisons In The German Early Benefit Assessment by Berkemeier, F, Bleß, H, Reindl, S, Ballhausen, A, Maltz, A

Get full text

Acceptance Of Indirect Comparisons In The German Early Benefit Assessment by Berkemeier, F, Bleß, H, Reindl, S, Ballhausen, A, Maltz, A

“…OBJECTIVES: Since 2011, newly marketed drugs undergo an early benefit assessment (EBA), in which the drug's additional benefit (AB) compared to an appropriate…”
Get full text

Intersystem-crossing and excited-state absorption of C70 studied by picosecond pump and probe absorption and fluorescence measurements by REINDL, S, PENZKOFER, A, GRATZ, H

Get full text

Intersystem-crossing and excited-state absorption of C 70 studied by picosecond pump and probe absorption and fluorescence measurements by Reindl, S., Penzkofer, A., Gratz, H.

“…The singlet and triplet absorption and emission dynamics of C 70 in toluene is studied with a picosecond Nd:glass laser double-pulse pump and probe…”
Get full text

Strong-excitation and weak-excitation photodisintegration of DODCI by REINDL, S, PENZKOFER, A

“…The disintegration yield of the organic dye DODCI dissolved in ethylene glycol and methanol due to cw excitation to the S sub(1)-state and due to intense…”
Get full text

PHP53 - Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones? by Kotowa, W, Reindl, S, Mathes, J, Doyno, T, Höer, A

Get full text